|
Market Cap (10-Jun) $47,863,656 (0th) |
Close (30-Jun) $0.85 |
Volume (30-Jun) 942,590 |
Shortsold (27-Oct) 800,001 (0.58%) (257th) |
|
52w High $0.490 |
52w Low $0.312 |
P/E - |
EPS -0.06 |
IIQ released this announcement to the ASX on 25 February 2022, 11:31. The announcement is marked as price sensitive, and is 21 page(s) in length and 686.7kb in size.
You can view all announcements from IIQ and see how they appear on a price chart on the announcements page.
At the date of this announcement, IIQ was 0.002% short sold according to ASIC data. It was ranked the 733rd most shorted stock on the ASX. It is now ranked as the 257th most shorted stock on the ASX with 0.576% of total shares short sold as of the latest reported data (27 October 2025).
| Other Recent Announcements from IIQ | |
|---|---|
| Notification of cessation of securities - IIQ | 30 June 2023, 14:19 |
| SubB2M/CA15.3 Clinical Validation Data Investor Presentation | 29 June 2023, 10:48 |
| INOVIQ Investor Briefing | 27 June 2023, 14:07 |
| Appendix 4D and Half Year Financial Report | 25 February 2022, 11:31 |
| Brazilian Patent Issued for Lung & Colorectal Cancer | 23 February 2022, 10:23 |
| Updated Investor Presentation | 3 February 2022, 12:06 |
| Notification regarding unquoted securities - IIQ | 31 January 2022, 16:30 |
You must be logged in to post a reply.
